BeStock  
Markets › Compare › RCUS vs VKTX

RCUS vs VKTX

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
RCUS · Arcus Biosciences$24.74 ▲ 1.23%
VKTX · Viking Therapeutics$29.28 ▼ 2.20%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

75115154194234Oct 7, '25Apr 7, '26Oct 5, '26
  • RCUS +76.3%
  • VKTX -7.2%

Head to head

MetricRCUSVKTX
Price$24.74$29.28
Change today▲ 1.23%▼ 2.20%
Market cap$3.15B$3.68B
Return, 3 months-18.2%-30.5%
Return, year to date+3.8%-16.8%
Return, 1 year+70.9%-9.3%
P/E (TTM)-6.3-6.3
P/B6.89.0
P/E percentile vs own 5y–81st
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)–-227.1%
Gross margin––
Operating margin––
Net margin––
Return on equity––
Analyst target vs. price+70.3%+209.0%
Analyst buy share89%94%
RSI (14)3941
30-day volatility47.3%108.4%
Max drawdown, 1 year-27.8%-35.5%
Trend readLeaning bearishStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • VKTX is the largest of the group by market value.
  • RCUS has returned the most over the past year.
  • RCUS carries the lowest trailing P/E.
  • RCUS has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top